Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo substantive changes were detected on the Study Details page; only minor formatting or layout adjustments are visible in the screenshots, and the core study data (objectives, design, eligibility criteria, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check49 days agoChange DetectedCore page content is largely unchanged; however, several MedlinePlus topics were removed and the page version updated to v3.1.0, indicating a cleanup of topics rather than addition of new content.SummaryDifference0.3%

- Check64 days agoChange DetectedUpdated page revision to v3.0.2, replacing v3.0.1. Removed the Back to Top link, a minor UI change.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check78 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name, location details, and various publications related to drug safety and therapeutic uses, while removing outdated location terms and references to eczema.SummaryDifference3%

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.